In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
We are very excited to launch our new website! Please take a few moments to click around and explore...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...